Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial

[1]  M. Rosenfeld,et al.  Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis , 2016, Pediatrics.

[2]  H. Blau,et al.  Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  B. Assael,et al.  Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial. , 2014, Journal of aerosol medicine and pulmonary drug delivery.

[4]  J. Stocks,et al.  An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. , 2013, Annals of the American Thoracic Society.

[5]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[6]  R. Kronmal,et al.  Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. , 2012, JAMA.

[7]  N. McElvaney,et al.  Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis , 2012, TheScientificWorldJournal.

[8]  S. Stanojevic,et al.  Reference ranges for interrupter resistance technique: the Asthma UK Initiative , 2009, European Respiratory Journal.

[9]  A. Chang,et al.  Interrupter respiratory resistance in healthy Chinese preschool children. , 2009, Chest.

[10]  V. McDonald,et al.  Nebulised hypertonic saline for cystic fibrosis. , 2009, The Cochrane database of systematic reviews.

[11]  S. Donaldson,et al.  Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis , 2008, Pediatric pulmonology.

[12]  Karen A Robinson,et al.  Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. , 2007, American journal of respiratory and critical care medicine.

[13]  Janet Stocks,et al.  An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. , 2007, American journal of respiratory and critical care medicine.

[14]  F. Ratjen,et al.  Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis , 2007, Pediatric pulmonology.

[15]  I. Doull,et al.  The interrupter technique to assess airway responsiveness in children with cystic fibrosis , 2007, Pediatric pulmonology.

[16]  F. Ratjen.  Restoring airway surface liquid in cystic fibrosis. , 2006, The New England journal of medicine.

[17]  Mark R Elkins,et al.  A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. , 2006, The New England journal of medicine.

[18]  M. Knowles,et al.  Mucus clearance and lung function in cystic fibrosis with hypertonic saline. , 2006, The New England journal of medicine.

[19]  C. Metcalfe,et al.  Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis , 2004, Pediatric pulmonology.

[20]  S. Conway,et al.  Airway Resistance Measurements in Children with Cystic Fibrosis , 2003 .

[21]  P. Sly,et al.  Measurement of lung function in preschool children using the interrupter technique , 2003, Thorax.

[22]  C. K. van der Ent,et al.  Applicability of interrupter resistance measurements using the MicroRint in daily practice. , 2003, Respiratory medicine.

[23]  A. Denjean,et al.  Pulmonary function tests in preschool children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[24]  C. Metcalfe,et al.  Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis , 2002, Thorax.

[25]  S. Ranganathan,et al.  Measurement of airway resistance using the interrupter technique in preschool children in the ambulatory setting. , 1999, The European respiratory journal.

[26]  M. King,et al.  Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. , 1997, Thorax.

[27]  M. King,et al.  Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. , 1997, American journal of respiratory and critical care medicine.

[28]  P. Cole,et al.  Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. , 1997, The Journal of clinical investigation.